| Author (Corporate) | European Medicines Evaluation Agency (EMEA) |
|---|---|
| Publisher | European Union |
| Series Details | EMEA/622721/2009 |
| Publication Date | 08/12/2009 |
| Content Type | News |
Summary:The EMEA's Committee for Medicine Products for Human Use (CHMP) decided in January 2009 that a thorough scientific discussion was necessary in order to establish the value and safe use of antimicrobial preservatives in eye drops for human use. An ad-hoc group of experts was established as a result and agreed on a number of conclusions as regards this matter. The conclusions were published by the EMEA on 8 December 2009. Further information:The EMEA became the European Medicines Agency (EMA) in December 2009. |
|
| Source Link | https://www.ema.europa.eu/en/documents/public-statement/emea-public-statement-antimicrobial-preservatives-ophthalmic-preparations-human-use_en.pdf |
| Subject Categories | Health |
| Subject Tags | Medicines | Medical Devices |
| International Organisations | European Union [EU] |
